|
HMGN4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.939200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.203600E-02 |
| Normal-vs-Stage2 |
2.015800E-03 |
| Normal-vs-Stage3 |
1.347590E-02 |
| Normal-vs-Stage4 |
1.089830E-02 |
| Stage1-vs-Stage2 |
2.776100E-02 |
| Stage1-vs-Stage3 |
2.968000E-01 |
| Stage1-vs-Stage4 |
2.881000E-01 |
| Stage2-vs-Stage3 |
2.037000E-01 |
| Stage2-vs-Stage4 |
3.151200E-01 |
| Stage3-vs-Stage4 |
8.209800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.474300E-02 |
| Normal-vs-AfricanAmerican |
7.662600E-01 |
| Normal-vs-Asian |
4.279900E-02 |
| Caucasian-vs-AfricanAmerican |
3.191800E-01 |
| Caucasian-vs-Asian |
6.318000E-01 |
| AfricanAmerican-vs-Asian |
2.391000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.717720E-03 |
| Normal-vs-Female |
2.739500E-02 |
| Male-vs-Female |
1.061650E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.580390E-01 |
| Normal-vs-Age(41-60Yrs) |
1.524250E-02 |
| Normal-vs-Age(61-80Yrs) |
3.161000E-04 |
| Normal-vs-Age(81-100Yrs) |
7.682400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.716600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.160330E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.571400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.156300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.829600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.701220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.486200E-01 |
| Classical-VS-Follicular |
2.5139999999535E-06 |
| Classical-VS-Other |
3.647600E-01 |
| Classical-VS-Normal |
3.025200E-01 |
| Tall-VS-Follicular |
3.940700E-03 |
| Tall-VS-Other |
3.883200E-01 |
| Tall-VS-Normal |
5.693600E-01 |
| Follicular-VS-Other |
4.555600E-01 |
| Follicular-VS-Normal |
3.44900000004422E-06 |
| Other-VS-Normal |
3.720800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.832600E-04 |
| Normal-vs-N1 |
9.413900E-04 |
| N0-vs-N1 |
3.514000E-01 |
|
|
